Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
| Autor: | Färkkilä, Markus, Diener, Hans-Christoph, Géraud, Gilles, Láinez, Miguel, Schoenen, Jean, Harner, Nadja, Pilgrim, Alison, Reuter, Uwe |
|---|---|
| Zdroj: | In Lancet Neurology May 2012 11(5):405-413 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|